IBBvsIBRN
iShares Biotechnology ETF against iShares Neuroscience and Healthcare ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBB | IBRN | |
|---|---|---|
| Expense ratio | 0.45% | 0.47% |
| Assets | $10.2B | $7931.50T |
| Net flow, 1 month | +$86M | +$2M |
| Net flow, 1 year | +$1.5B | +$2M |
| Return, YTD | +28.4% | +27.9% |
| Return, 1 year | +57.3% | +68.6% |
| Avg daily volume | 1.4M | 3K |
| Holdings | 221 | 54 |
| Listed | Feb 4, 2001 | Aug 23, 2022 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS